CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in CytomX Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −7 vs. Q2 2021
- Shares held
- 54.0M
- −2.65M (−4.7%) vs. Q2 2021
- Total value
- $274.8M
- −$83.7M (−23.4%) vs. Q2 2021
- New holders
- 10
- 36 more added
- Sold out
- 17
- 45 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 178 | $799.0M |
| Q1 2026 | 179 | $911.2M |
| Q4 2025 | 122 | $613.9M |
| Q3 2025 | 103 | $438.4M |
| Q2 2025 | 83 | $302.6M |
| Q1 2025 | 66 | $28.8M |
| Q4 2024 | 70 | $48.1M |
| Q3 2024 | 69 | $60.4M |
| Q2 2024 | 74 | $61.9M |
| Q1 2024 | 88 | $97.1M |
| Q4 2023 | 68 | $50.6M |
| Q3 2023 | 62 | $41.8M |
| Q2 2023 | 67 | $58.7M |
| Q1 2023 | 76 | $53.7M |
| Q4 2022 | 81 | $57.5M |
| Q3 2022 | 84 | $52.6M |
| Q2 2022 | 99 | $83.4M |
| Q1 2022 | 119 | $143.4M |
| Q4 2021 | 110 | $236.5M |
| Q3 2021 | 114 | $274.8M |
| Q2 2021 | 122 | $358.9M |
| Q1 2021 | 126 | $422.2M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding CytomX Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 1,109,065 | $5.64M | 0.00% | +157,048+16.5% | Added |
| Geode Capital Management, LLC | 1,123,083 | $5.72M | 0.00% | −29,927−2.6% | Reduced |
| Altium Capital Management LP | 1,233,642 | $6.28M | 1.68% | +371,225+43.0% | Added |
| Jacobs Levy Equity Management, Inc | 1,394,070 | $7.10M | 0.05% | −19,797−1.4% | Reduced |
| RTW Investments, LP | 1,400,939 | $7.13M | 0.11% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,500,000 | $7.63M | 1.81% | +500,000+50.0% | Added |
| OrbiMed Advisors LLC | 1,821,868 | $9.27M | 0.10% | +308,700+20.4% | Added |
| Victory Capital Management Inc | 3,269,112 | $16.6M | 0.02% | +400,126+13.9% | Added |
| Candriam Luxembourg S.C.A. | 3,305,940 | $16.8M | 0.11% | +977,587+42.0% | Added |
| Ra Capital Management, L.P. | 3,500,000 | $17.8M | 0.25% | 00.0% | Unchanged |
| State Street Corp | 4,036,937 | $20.5M | 0.00% | −579,625−12.6% | Reduced |
| BlackRock Inc. | 5,052,601 | $25.7M | 0.00% | −28,022−0.6% | Reduced |
| Vanguard Group Inc | 5,516,321 | $28.1M | 0.00% | +158,236+3.0% | Added |
| Point72 Asset Management, L.P. | 6,303,025 | $32.1M | 0.15% | −90,875−1.4% | Reduced |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,640,957−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −769,766−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −195,157−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −84,724−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −64,469−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −55,035−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −39,463−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −22,840−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,422−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,101−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −15,182−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −13,175−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −10,582−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,059−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −412−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |